Author Correction: Sepsis-trained macrophages promote antitumoral tissue-resident T cells

Alexis Broquet; Victor Gourain; Thomas Goronflot; Virginie Le Mabecque; Debajyoti Sinha; Mitra Ashayeripanah; Cédric Jacqueline; Pierre Martin; Marion Davieau; Lea Boutin; Cecile Poulain; Florian P Martin; Cynthia Fourgeux; Melanie Petrier; Manon Cannevet; Thomas Leclercq; Maeva Guillonneau; Tanguy Chaumette; Thomas Laurent; Christelle Harly; Emmanuel Scotet; Laurent Legentil; Vincent Ferrières; Stephanie Corgnac; Fathia Mami-Chouaib; Jean Francois Mosnier; Nicolas Mauduit; Hamish E G McWilliam; Jose A Villadangos; Pierre Antoine Gourraud; Karim Asehnoune; Jeremie Poschmann; Antoine Roquilly

doi:10.1038/s41590-024-02000-x

Author Correction: Sepsis-trained macrophages promote antitumoral tissue-resident T cells

Nat Immunol. 2024 Nov;25(11):2167. doi: 10.1038/s41590-024-02000-x.

Authors

Alexis Broquet^#^{1

2}, Victor Gourain^#¹, Thomas Goronflot^#³, Virginie Le Mabecque¹, Debajyoti Sinha¹, Mitra Ashayeripanah⁴, Cédric Jacqueline¹, Pierre Martin¹, Marion Davieau^{1

2}, Lea Boutin¹, Cecile Poulain^{1

2}, Florian P Martin^{1

2}, Cynthia Fourgeux¹, Melanie Petrier¹, Manon Cannevet², Thomas Leclercq¹, Maeva Guillonneau^{1

5}, Tanguy Chaumette¹, Thomas Laurent¹, Christelle Harly⁶, Emmanuel Scotet⁶, Laurent Legentil⁷, Vincent Ferrières⁷, Stephanie Corgnac⁸, Fathia Mami-Chouaib⁸, Jean Francois Mosnier⁹, Nicolas Mauduit¹⁰, Hamish E G McWilliam⁴, Jose A Villadangos^{4

11}, Pierre Antoine Gourraud^{1

3}, Karim Asehnoune^{1

2}, Jeremie Poschmann¹², Antoine Roquilly^{13

14

15}

Affiliations

¹ Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology UMR 1064, Nantes, France.
² CHU Nantes, INSERM, Nantes Université, Anesthesie Reanimation, CIC 1413, Nantes, France.
³ CHU Nantes, Pôle Hospitalo-Universitaire 11: Santé Publique, Clinique des Données, INSERM, Nantes Université, CIC 1413, Nantes, France.
⁴ Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
⁵ Olgram SAS, Bréhan, France.
⁶ Nantes Université, INSERM, CRC2INA, Nantes, France.
⁷ Ecole Nationale Supérieure de Chimie de Rennes, Université de Rennes, ISCR - UMR CNRS 6226, Rennes, France.
⁸ INSERM UMR 1186, Integrative Tumour Immunology and Immunotherapy, Gustave Roussy, Faculty de Médecine, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
⁹ CHU Nantes, Nantes Université, Anatomo-pathologie, Nantes, France.
¹⁰ CHU Nantes, Nantes Université, PMSI, Nantes, France.
¹¹ Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
¹² Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology UMR 1064, Nantes, France. [email protected].
¹³ Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology UMR 1064, Nantes, France. [email protected].
¹⁴ CHU Nantes, INSERM, Nantes Université, Anesthesie Reanimation, CIC 1413, Nantes, France. [email protected].
¹⁵ Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia. [email protected].

^# Contributed equally.

PMID: 39375552
DOI: 10.1038/s41590-024-02000-x

No abstract available

Publication types

Published Erratum